Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
437.8 INR | -3.84% | -10.18% | +21.21% |
20/05 | Solara Active Pharma Gets Zero Observations from US FDA for Andhra Pradesh, India Unit | MT |
10/05 | Solara Active Pharma to Raise 4.50 Billion Via Rights Issue | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+21.21% | 263M | |
+38.51% | 727B | |
+31.96% | 594B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+14.80% | 243B | |
+7.73% | 205B | |
-5.93% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- SOLARA Stock
- News Solara Active Pharma Sciences Limited
- Transcript : Solara Active Pharma Sciences Limited, Q4 2020 Earnings Call, May 07, 2020